Received Aug 26, 2025
| Type | Name | Manufacturer | Dose | Lot | Route / Site |
|---|---|---|---|---|---|
| PNC15 | PNEUMO (VAXNEUVANCE) | MERCK & CO. INC. | UNK | Y010032 | — |
| PPV | PNEUMO (PNEUMOVAX) | MERCK & CO. INC. | UNK | Y016291 | — |
patient received both PNEUMOVAX 23 and VAXNEUVANCE on the same day; No adverse symptoms reported; This spontaneous report was received from a Nurse and refers to a 66-year-old patient of unknown gender. The patient's medical history was not reported. The patient's concurrent conditions were not reported. Concomitant therapies were not reported. On an unknown date, the patient was vaccinated on the same day with both Pneumococcal Vaccine, Polyvalent (23-valent) (PNEUMOVAX 23) suspension for injection, lot #Y016291, expiration date: 06-Dec-2026 (dose, route and site of administration not provided), and with Pneumococcal 15-valent Conjugate Vaccine (VAXNEUVANCE) suspension for injection, lot #Y010032, expiration date: 17-Feb-2027, 0.5 ml (route and site of administration not provided) for prophylaxis (accidental overdose). No adverse symptoms reported (no adverse event). Permission to contact was given.